Skip to main content
Premium Trial:

Request an Annual Quote

US DoD Taps CombiMatrix to Develop Point-of-Care Testing System

NEW YORK (GenomeWeb News) – The US Department of Defense has awarded CombiMatrix a fifteen-month contract worth more than $900,000 to develop a hand-held detection system for military use, the company said today.
 
The contract follows a one-year, $2.2 million agreement the company signed last July with the DoD to develop microarrays to detect pathogens and toxins, and two DoD awards that it won in 2006.
 
CombiMatrix said today that the instrument it will develop under the new contract will be the “size of a deck of playing cards,” which will allow it to be used in the field of operations in military applications.
 
The company said it expects the system will also be of interest in the civilian market for point-of-care testing “as well as other applications and markets that are currently not accessible due to instrument size, complexity and/or expense.”

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.